EUVIMEDEUVIMED entdecken
Crossref

Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells

Kai Yang, Yukai Zhu, Jin Chen, Weifeng Zhou

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Kai Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology, Anhui Medical College, Hefei, 230601, China. Electronic address: yangkai@ahyz.edu.cn. Hauptthemen laut MEDLINE: Hepatitis B virus, Virus Replication, Myxovirus Resistance Proteins, Interleukin-8. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Anhui Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro studies have revealed that hepatitis B virus (HBV) infection upregulates interleukin-8 (IL-8), which enhances HBV replication. Clinically, elevated IL-8 levels in chronic HBV patients are associated with diminished therapeutic efficacy of interferon-α (IFN-α). Our study advances these findings by demonstrating that IL-8 promotes the expression of myxovirus resistance A (MxA) and protein kinase R (PKR) in HepG2 cells via the PI3K-AKT pathway. However, HBV-infected cells fail to exhibit IL-8-induced upregulation of MxA and PKR, likely due to HBV's upregulation of PP2A that inhibits the PI3K-AKT pathway. Notably, IL-8 targets the C/EBPα transcription factor, increasing HBV promoter activity and viral replication, which in turn partially suppresses the expression of MxA and PKR induced by IFN-α. Our findings uncover a mechanism by which HBV may evade immune responses, suggesting potential new strategies for immunotherapy against chronic HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusVirus ReplicationMyxovirus Resistance ProteinsInterleukin-8HumansHep G2 CellseIF-2 KinaseInterferon-alphaProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

HBVHepG2Interleukin-8MxAPKR

Substanzen

Myxovirus Resistance ProteinsInterleukin-8MX1 protein, humaneIF-2 KinaseInterferon-alphaEIF2AK2 protein, humanProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Medical Technology, Anhui Medical College, Hefei, 230601, China. Electronic address: yangkai@ahyz.edu.cn.
  • School of Medical Technology, Anhui Medical College, Hefei, 230601, China.
  • School of Clinical Medicine, Anhui Medical College, Hefei, 230601, China.

Förderung

  • Anhui Provincial Natural Science Foundation

Zitieren

APA

Yang, K., Zhu, Y., Chen, J., & Zhou, W. (2024). Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150455

Vancouver

Yang K, Zhu Y, Chen J, Zhou W. Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150455

BibTeX
@article{Yang2024,
  author = {Yang, Kai and Zhu, Yukai and Chen, Jin and Zhou, Weifeng},
  title = {Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150455}
}
Kostenlos starten →